SE417610B - Analogiforfarande for framstellning av 1-bensazolylalkyl-4-substituerade piperidiner - Google Patents
Analogiforfarande for framstellning av 1-bensazolylalkyl-4-substituerade piperidinerInfo
- Publication number
- SE417610B SE417610B SE7611137A SE7611137A SE417610B SE 417610 B SE417610 B SE 417610B SE 7611137 A SE7611137 A SE 7611137A SE 7611137 A SE7611137 A SE 7611137A SE 417610 B SE417610 B SE 417610B
- Authority
- SE
- Sweden
- Prior art keywords
- bensazolylalkyl
- preparation
- substituted piperidines
- analogy procedure
- analogy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62072775A | 1975-10-08 | 1975-10-08 | |
| US05/713,309 US4035369A (en) | 1975-10-08 | 1976-08-10 | 1-Benzazolylalkyl-4-substituted-piperidines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7611137L SE7611137L (sv) | 1977-04-09 |
| SE417610B true SE417610B (sv) | 1981-03-30 |
Family
ID=27088773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7611137A SE417610B (sv) | 1975-10-08 | 1976-10-07 | Analogiforfarande for framstellning av 1-bensazolylalkyl-4-substituerade piperidiner |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4035369A (fi) |
| JP (1) | JPS5246082A (fi) |
| AT (1) | AT365185B (fi) |
| AU (1) | AU511834B2 (fi) |
| BG (1) | BG27542A3 (fi) |
| CA (1) | CA1085853A (fi) |
| CH (1) | CH630915A5 (fi) |
| CS (1) | CS225101B2 (fi) |
| DE (1) | DE2645125A1 (fi) |
| DK (1) | DK151801C (fi) |
| EG (1) | EG12969A (fi) |
| ES (1) | ES452200A1 (fi) |
| FI (1) | FI63228C (fi) |
| FR (1) | FR2346009A1 (fi) |
| GB (1) | GB1532546A (fi) |
| GR (1) | GR61672B (fi) |
| HU (1) | HU174927B (fi) |
| IE (1) | IE43951B1 (fi) |
| IL (1) | IL50631A (fi) |
| IT (1) | IT1069293B (fi) |
| LU (1) | LU75954A1 (fi) |
| NL (1) | NL7611085A (fi) |
| NO (1) | NO144926C (fi) |
| NZ (1) | NZ182134A (fi) |
| PH (1) | PH15417A (fi) |
| PL (1) | PL106815B1 (fi) |
| PT (1) | PT65688B (fi) |
| RO (1) | RO69904A (fi) |
| SE (1) | SE417610B (fi) |
| SU (1) | SU663306A3 (fi) |
| YU (1) | YU39976B (fi) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200641A (en) * | 1976-12-21 | 1980-04-29 | Janssen Pharmaceutica, N.V. | 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives |
| US4335127A (en) * | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
| IE810250L (en) * | 1980-02-11 | 1981-08-11 | Berlex Lab | N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines. |
| US4254127A (en) * | 1980-04-03 | 1981-03-03 | Janssen Pharmaceutica, N.V. | 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives |
| DE3442757A1 (de) * | 1984-11-23 | 1986-05-28 | Wella Ag, 6100 Darmstadt | Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate |
| KR930005004B1 (ko) * | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법 |
| FR2581993B1 (fr) * | 1985-05-14 | 1988-03-18 | Synthelabo | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique |
| FR2702214B1 (fr) * | 1993-03-05 | 1995-04-14 | Adir | Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
| GB9418326D0 (en) * | 1994-09-12 | 1994-11-02 | Lilly Industries Ltd | Pharmaceutical compounds |
| DE69531476T2 (de) | 1994-09-12 | 2004-06-09 | Lilly Industries Ltd., Basingstoke | Serotonergische Modulatoren |
| GB2308362A (en) * | 1995-12-19 | 1997-06-25 | Lilly Industries Ltd | Pharmaceutical indole derivatives |
| GB9613423D0 (en) * | 1996-06-26 | 1996-08-28 | Lilly Industries Ltd | Pharmaceutical compounds |
| JP2010503722A (ja) * | 2006-09-19 | 2010-02-04 | シプラ・リミテッド | シクレソニドとその結晶変異体の調製方法 |
| CN101759693B (zh) * | 2008-12-23 | 2011-09-14 | 江苏恩华药业股份有限公司 | 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用 |
| CA3211341A1 (en) * | 2021-03-19 | 2022-09-22 | Centre National De La Recherche Scientifique | Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE633495A (fi) * | 1962-06-13 | |||
| US3225052A (en) * | 1964-05-06 | 1965-12-21 | Janssen Pharmaceutica Nv | Benzimidazolinyl piperidine derivatives |
| FR1573739A (fi) | 1968-07-26 | 1969-07-04 | ||
| US3647790A (en) * | 1969-04-08 | 1972-03-07 | American Home Prod | Ouinoxalinyl-oxazolidines and -oxazines |
-
1976
- 1976-08-10 US US05/713,309 patent/US4035369A/en not_active Expired - Lifetime
- 1976-09-22 NZ NZ182134A patent/NZ182134A/xx unknown
- 1976-09-23 AU AU18078/76A patent/AU511834B2/en not_active Expired
- 1976-09-28 PH PH18950A patent/PH15417A/en unknown
- 1976-10-01 CA CA262,478A patent/CA1085853A/en not_active Expired
- 1976-10-05 FR FR7629928A patent/FR2346009A1/fr active Granted
- 1976-10-05 GR GR51849A patent/GR61672B/el unknown
- 1976-10-05 EG EG605/76A patent/EG12969A/xx active
- 1976-10-06 GB GB41465/76A patent/GB1532546A/en not_active Expired
- 1976-10-06 DE DE19762645125 patent/DE2645125A1/de active Granted
- 1976-10-06 IT IT51612/76A patent/IT1069293B/it active
- 1976-10-06 CH CH1265376A patent/CH630915A5/de not_active IP Right Cessation
- 1976-10-07 AT AT0745276A patent/AT365185B/de active
- 1976-10-07 IL IL50631A patent/IL50631A/xx unknown
- 1976-10-07 DK DK452076A patent/DK151801C/da not_active IP Right Cessation
- 1976-10-07 ES ES452200A patent/ES452200A1/es not_active Expired
- 1976-10-07 NO NO763424A patent/NO144926C/no unknown
- 1976-10-07 SE SE7611137A patent/SE417610B/xx not_active IP Right Cessation
- 1976-10-07 PL PL1976192890A patent/PL106815B1/pl not_active IP Right Cessation
- 1976-10-07 JP JP51119933A patent/JPS5246082A/ja active Granted
- 1976-10-07 LU LU75954A patent/LU75954A1/xx unknown
- 1976-10-07 PT PT65688A patent/PT65688B/pt unknown
- 1976-10-07 FI FI762865A patent/FI63228C/fi not_active IP Right Cessation
- 1976-10-07 NL NL7611085A patent/NL7611085A/xx not_active Application Discontinuation
- 1976-10-07 IE IE2212/76A patent/IE43951B1/en unknown
- 1976-10-08 CS CS766511A patent/CS225101B2/cs unknown
- 1976-10-08 YU YU2480/76A patent/YU39976B/xx unknown
- 1976-10-08 RO RO197687960Q patent/RO69904A/ro unknown
- 1976-10-08 HU HU76JA771A patent/HU174927B/hu not_active IP Right Cessation
- 1976-10-08 SU SU762407707A patent/SU663306A3/ru active
- 1976-10-08 BG BG034394A patent/BG27542A3/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE430335B (sv) | Analogiforfarande for framstellning av pyridinyl-pyridinoner | |
| SE433208B (sv) | Forfarande for framstellning av fenoletrar | |
| SE420354B (sv) | Forfarande for teknisk framstellning av forbeskiktade objektplattor | |
| RO72997A (ro) | Procedeu pentru prepararea benzoilureido-nitro-difenileteri | |
| SE431872B (sv) | Analogiforfarande for framstellning av derivat av 4-pyrimidon | |
| SE7601390L (sv) | Forfarande for framstellning av kiselorganiska kompositioner | |
| SE7605139L (sv) | Forfarande for framstellning av vattenupptagande cellulosaetrar | |
| SE417610B (sv) | Analogiforfarande for framstellning av 1-bensazolylalkyl-4-substituerade piperidiner | |
| SE430336B (sv) | Forbettrat forfarande for framstellning av amoxicillinfrihydrat | |
| SE426490B (sv) | Analogiforfarande for framstellning av 1-(bensazolylalkyl)piperidiner | |
| SE428296B (sv) | Analogiforfarande for framstellning av substituerade difonylsulfider | |
| SE427839B (sv) | Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider | |
| NO139555C (no) | Fremgangsmaate for fremstilling av fosgen | |
| NO146058C (no) | Analogifremgangsmaate for fremstilling av substituerte benzamider | |
| SE421422B (sv) | Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin | |
| SE7606116L (sv) | Forfarande for framstellning av 3-fenoxidbensaldehyder | |
| SE427841B (sv) | Analogiforfarande for framstellning av tienamycinderivat | |
| SE7604781L (sv) | Forfarande for framstellning av diarylhydroxibutylaminer | |
| SE421793B (sv) | Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat | |
| SE427840B (sv) | Analogiforfarande for framstellning av tienamycinderivat | |
| SE423233B (sv) | Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner | |
| SE7602696L (sv) | Forfarande for framstellning av fernissa baserad pa polyesterharts | |
| SE446726B (sv) | Forfarande for framstellning av 16-metoxiprostaglandiner | |
| SE7610637L (sv) | Forfarande for framstellning av 2-alkylindaner | |
| SE427558B (sv) | Analogiforfarande for framstellning av 7-metoxicefalosporinderivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7611137-6 Effective date: 19910507 Format of ref document f/p: F |